BIOFRONTERA AG NA O.N./ DE0006046113 /
| 2024-04-19 10:13:46 AM | Chg. -0.052 | Volume | Bid1:30:00 PM | Ask1:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.298EUR | -14.86% | 20,077 Turnover: 6,015.100 |
0.306Bid Size: 4,000 | 0.334Ask Size: 3,500 | 16.45 mill.EUR | 0.00% | 0.42 |
Assets
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .7000 | .8000 | 5.2000 | 5.1000 | 2.3000 | ||||||
| Intangible Assets | .6000 | .4000 | 22.8000 | 17.7000 | 1.1000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 53.2000 | ||||||
| Fixed Assets | 1.4000 | 11.5000 | 35.9000 | 30.3000 | 62.3000 | ||||||
| Inventories | 3.7000 | 3.2000 | 4.1000 | 4.7000 | 4.8000 | ||||||
| Accounts Receivable | 1.6000 | 3.4000 | 5 | 3.5000 | .8000 | ||||||
| Cash and Cash Equivalents | 11.1000 | 19.5000 | 11.1000 | 16.5000 | 6.9000 | ||||||
| Current Assets | 18.5000 | 27.6000 | 22.5000 | 26.1000 | 14.4000 | ||||||
| Total Assets | 19.8000 | 39.1000 | 58.4000 | 56.4000 | 76.7000 | ||||||
Liabilities
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.1000 | 1.8000 | 4.2000 | 1.6000 | 2.7000 | ||||||
| Long-term debt | 12.4000 | 13.5000 | 36.8000 | 40.7000 | 1.2000 | ||||||
| Liabilities to Banks | 12.6000 | 13.7000 | 38.1000 | 41.9000 | 3.6000 | ||||||
| Provisions | 2.5000 | 5.8000 | 6.1000 | 5.4000 | 7 | ||||||
| Liabilities | 16.5000 | 22.8000 | 48.4000 | 49 | 18.7000 | ||||||
| Share Capital | 38.4170 | 44.6320 | 44.8490 | 47.7480 | 56.7170 | ||||||
| Total Equity | 3.4000 | 16.4000 | 10 | 7.4000 | 58 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 19.8000 | 39.1000 | 58.4000 | 56.4000 | 76.7000 | ||||||
Income Statement
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 12 | 21.1000 | 31.3000 | 30.3000 | 28.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -13.9000 | -18.5000 | -23.4000 | -7.6000 | 24.7000 | ||||||
| Interest Income | -1.0620 | -1.7760 | -2.6000 | -2.7000 | -3.6900 | ||||||
| Income Before Taxes | -16.1000 | -19.3000 | -4.8000 | -12.7000 | 35.7000 | ||||||
| Income Taxes | 0.0000 | -10.4000 | 2.6000 | .3000 | 1.8000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 4.5000 | ||||||
| Net Income | -16.1000 | -8.9000 | -7.4000 | -13 | 38.3000 | ||||||
Per Share
Cash Flow
|
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -13.1000 | -13.4000 | -32.9000 | -2.8000 | 30.4000 | ||||||
| Cash Flow from Investing Activities | -.4000 | -.5000 | 21.1000 | 2.9000 | -42.3000 | ||||||
| Cash Flow from Financing | 9.5000 | 22.3000 | 3.5000 | 5.9000 | 2.2000 | ||||||
| Decrease / Increase in Cash | -4 | 8.3000 | -8.4000 | 6 | -9.6000 | ||||||
| Employees | 119 | 141 | 180 | 157 | 163 | ||||||
